Don t shortchange public trust in science #MMPMID32935085
ä
Nat Cancer 2020[]; 1 (9): 855-856 PMID32935085show ga
The need to address COVID-19 is placing huge demands on biomedical research and regulatory processes. Under pressure, it is essential to uphold high bioethical principles and rigorous standards for the development and approval of medicines.